Alemtuzumab Controls Acute GVHD and Mixed Chimerism Risks in Pediatric Patients With HLH Undergoing Stem Cell Transplantation: A Correlative Biology Study From the CTN 1204 Richi Trial
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.218
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Elsevier BV